Drug abuse treatment as an HIV prevention strategy: A review

Drug and Alcohol Dependence

Volumn 59, Issue 1, 2000, Pages 17-31

  Sorensen, James L ^a   Copeland, Amy L ^a,b  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

HIV AIDS prevention; Methadone maintenance; Risk behavior; Treatment

Indexed keywords

METHADONE;

CLINICAL TRIAL; DATA BASE; DRUG ABUSE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; HEALTH CARE PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCIENTIFIC LITERATURE; SEXUAL BEHAVIOR; VIRUS TRANSMISSION;

CLINICAL TRIALS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; METHADONE; OPIOID-RELATED DISORDERS; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0034002158     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(99)00104-0     Document Type: Review

References (69)

1. Abbott, P.J., Moore, B.A., Weller, S.B., Delaney, H.D., 1998. AIDS risk behavior in opioid dependent patients treated with community reinforcement approach and relationships with psychiatric disorders. J. Addict. Dis. 17, 33-48.
2. Auerbach, J.D., Wypijewska, C., Brodie, H.K.H. (Eds.), 1994. AIDS and Behavior: An Integrated Approach. National Academy of Sciences, Washington, DC.
3. Avins, A.L., Lindan, C.P., Woods, W.J., Hudes, E.S., Boscarino, J.A., Kay, J., Clark, W., Hulley, S.B., 1997. Changes in HIV-related behaviors among heterosexual alcoholics following addiction treatment. Drug Alcohol Depend. 44, 47-55.
4. Bailar, J.C. III, 1997. The promise and problems of meta-analysis. N. Engl. J. Med. 337, 559-560.
5. Baker, A., Kochan, N., Dixon, J., Wodak, A., Heather, N., 1995. HIV risk-taking behavior among injecting drug users currently, previously, and never enrolled in methadone treatment. Addiction 90, 545-554.
6. Ball, J.C., Lange, W.R., Myers, C.P., Friedman, S.R., 1988. Reducing the risk of AIDS through methadone maintenance treatment. J. Health Soc. Behav. 29, 214-226.
7. Bellis, D.J., 1993. Reduction of AIDS risk among 41 heroin addicted women street prostitutes: effects of free methadone maintenance. J. Addict. Dis. 12, 7-23.
8. Calsyn, D.A., Saxon, A.J., Freeman, G., Whittaker, S., 1991. Needle-use practices among intravenous drug users in an area where needle purchase is legal. AIDS 5, 187-193.
9. Calsyn, D.A., Saxon, A.J., Freeman, G., Whittaker, S., 1992. Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users. Am. J. Public Health 82, 573-575.
10. Camacho, L.M., Bartholomew, N.G., Joe, G.W., Cloud, M.A., Simpson, D.D., 1996. Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance. Drug Alcohol Depend. 41, 1-7.
11. Caplehorn, J.M.M., Ross, M.W., 1995. Methadone maintenance and the likelihood of risky needle-sharing. Int. J. Addict. 30, 685-698.
12. Celentano, D.D., Munoz, A., Cohn, S., Nelson, K.E., Vlahov, D., 1994. Drug-related behavior change for HIV transmission among American injection drug users. Addiction 89, 1309-1317.
13. Centers for Disease Control and Prevention, 1998. HIV/AIDS surveillance report, 10(2), Atlanta, GA.
14. Cohen, E., Navaline, H., Metzger, D., 1994. High-risk behaviors for HIV: a comparison between crack-abusing and opioid-abusing African-American women. J Psychoactive Drugs 26, 233-241.
15. D'Aunno, T., Vaughn, T.E., 1995. An organizational analysis of service patterns in outpatient drug abuse treatment units. J. Subst. Abuse 7, 27-42.
16. DeNoon, D.J., 1996. Commentary: protease inhibitors: The good and the bad. AIDS Weekly, 3-5.
17. Des Jarlais, D.C., Friedman, S.R., Casriel, C., 1990. Target groups for preventing AIDS among intravenous drug users: 2. The 'hard' data studies. J. Consult. Clin. Psychol. 58, 50-56.
18. Des Jarlais, D.C., Paone, D., Milliken, J., Turner, C.F., Miller, H., Gribble, J., Shi, Q., Hagan, H., Friedman, S.R., 1999. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet 353, 1657-1661.
19. Dole, V.P., Nyswander, M., 1965. A medical treatment for diacetylmorphine (heroin) addiction. J. Am. Med. Assoc. 193, 80-84.
20. Drugs Used for Treatment of Narcotic Addicts, 1998. 21 C.F.R. §291.505, Federal Register, p. 135.
21. Etheridge, R.M., Craddock, S.G., Dunteman, G.H., Hubbard, R.L., 1995. Treatment services in two national studies of community-based drug abuse treatment programs. J. Subst. Abuse 7, 9-26.
22. Finn, P., 1994. Addressing the needs of cultural minorities in drug treatment. J. Subst. Abuse Treat. 4, 325-337.
23. Gottheil, E., Lundy, A., Weinstein, S.P., Sterling, R.C., 1998. Does intensive outpatient cocaine treatment reduce AIDS risky behaviors? J. Addict. Dis. 17, 61-69.
24. Gottheil, E., Sterling, R.C., Weinstein, S.P., 1993. Diminished illicit drug use as a consequence of long-term methadone maintenance. J. Addict. Dis. 12, 45-57.
25. Greenfield, L., Bigelow, G.E., Brooner, R.K., 1995. Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors. Drug Alcohol Depend. 39, 91-98.
26. Hartel, D.M., Schoenbaum, E.E., 1998. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep. 113 (Suppl. 1), 107-115.
27. Hubbard, R.L., Craddock, S.G., Flynn, P.M., Anderson, J., Etheridge, R.M., 1997. Overview of 1-year follow-up outcomes in the drug abuse treatment outcome study (DATOS). Psychol. Addict. Behav. 11, 261-268.
28. Hubbard, R.L., Marsden, M.E., Rachal, J.V., Harwood, H.J., Cavanaugh, E.R., Ginzburg, H.M., 1989. Drug Abuse Treatment: A National Study of Effectiveness. University of North Carolina Press, Chapel Hill, NC.
29. Iguchi, M.Y., 1998. Drug abuse treatment as HIV prevention: changes in social drug use patterns might also reduce risk. J. Addict. Dis. 17, 9-18.
30. Inciardi, J.A., 1990. Federal efforts to control the spread of HIV and AIDS among IV drug users. Am. Behav. Sci. 33, 408-418.
31. John, S., Brown, L.S., Primm, B.J., 1997. African Americans: Epidemiologic, prevention, and treatment issues. In: Lowinson, J.H., Ruiz, P., Millman, R.R., Langrod, J.G. (Eds.), Comprehensive Textbook of Substance Abuse, 3rd ed. Williams and Wilkins, Baltimore, MD, pp. 699-705.
32. Klee, H., Faugier, J., Hayes, C., Morris, J., 1991. The sharing of injecting equipment among drug users attending prescribing clinics and those using needle-exchanges. Br. J. Addict. 86, 217-223.
33. Lamb, S., Greenlick, M.R., McCarty, D. (Eds.), 1998. Bridging the Gap Between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment. National Academy Press, Washington, DC.
34. Lampinen, T.M., 1991. Cost-effectiveness of drug abuse treatment for primary prevention of acquired immunodeficiency syndrome: epidemiologic considerations. NIDA Res. Monogr. 113, 114-128.
35. Latkin, C., Vlahov, D., Anthony, J.C., 1993. Socially desirable response and self-reported HIV infection among intravenous drug users. Br. J. Addict. 88, 517-526.
36. Longshore, D., Hsieh, S., 1998. Drug abuse treatment and risky sex: evidence for a cumulative treatment effect? Am. J. Drug Alcohol Abuse 24, 439-451.
37. Longshore, D., Hsieh, S., Anglin, M.D., 1994. Reducing HIV risk behavior among injection drug users: Effects of methadone maintenance treatment on number of sex partners. Int. J. Addict. 29, 741-757.
38. Longshore, D., Hsieh, S., Danila, B., Anglin, M.D., 1993. Methadone maintenance and needle/syringe sharing. Int. J. Addict. 28, 983-996.
39. Magura, S., Rosenblum, A., Rodriquez, E.M., 1998. Changes in HIV risk behaviors among cocaine-using methadone patients. J. Addict. Dis. 17, 71-90.
40. Magura, S., Shapiro, J.L., Siddiqi, Q., Lipton, D.S., 1990. Variables influencing condom use among intravenous drug users. Am. J. Public Health 80, 82-84.
41. Marsch, L.A., 1998. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction 93, 515-532.
42. McCusker, J., Bigelow, C., Luippold, R., Zorn, M., Lewis, B.F., 1995. Outcomes of a 21-day drug detoxification program: Retention, transfer to further treatment, and HIV risk reduction. Am. J. Drug Alcohol Abuse 21, 1-16.
43. McCusker, J., Bigelow, C., Stoddard, A.M., Zorn, M., 1994. Human immunodeficiency virus type 1 antibody status and changes in risk behavior among drug users. Ann. Epidemiol. 4, 466-471.
44. McCusker, J., Willis, G., Vickers-Lahti, Lewis, B., 1998. Readmissions to drug abuse treatment and HIV risk behavior. Am. J. Drug Alcohol Abuse 24, 523-540.
45. Meandzija, B., O'Connor, P.G., Fitzgerald, B., Rounsaville, B.J., Kosten, T.R., 1994. HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug Alcohol Depend. 36, 109-113.
46. Metzger, D.S., Navaline, H., Woody, G.E., 1998. Drug abuse treatment as AIDS prevention. Public Health Rep. (Suppl.) 118, 97-106.
47. Metzger, D.S., Woody, G.E., McLellan, A.T., O'Brien, C.P., Druley, P., Navaline, H., DePhilippis, D., Stolley, P., Abrutyn, E., 1993. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J. Acquir. Immune Defic. Syndr. 6, 1049-1056.
48. Moss, A.R., Vranizan, K., Gorter, R., Bacchetti, P., Watters, J., Osmond, D., 1994. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS 8, 223-231.
49. Neaigus, A., Sufian, M., Friedman, S.R., Goldsmith, D.S., Stepherson, B., Mota, P., 1990. Effects of outreach intervention on risk reduction among intravenous drug users. AIDS Educ. Prev. 2, 253-271.
50. Normand, J., Vlahov, D., Moses, L.E. (Eds.), 1995. Preventing HIV Transmission: The Role of Sterile Needles and Bleach. National Academy Press, Washington, DC.
51. Novick, D.M., Joseph, H., Croxson, T.S., Salsitz, E.A., Wang, G., Richman, B.L., Poretsky, L., Keefe, J.B., Whimbey, E., 1990. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients. Arch. Intern. Med. 150, 97-99.
52. O'Connor, P.G., Selwyn, P.A., 1997. Medical issues in the care of opioid-dependent patients. In: Kosten, T.R., Stine, S.M. (Eds.), New Treatments for Opiate Dependence. Guilford, New York, pp. 199-227.
53. O'Connor, P., Selwyn, P.A., Schottenfeld, R.S., 1994. Medical care for injection-drug users with human immunodeficiency virus infection. N. Engl. J. Med. 331, 450-459.
54. Perez-Arce, P., Carr, K.D., Sorensen, J.L., 1993. Cultural issues in an outpatient program for stimulant abusers. J. Psychoactive Drugs 25, 35-44.
55. Prendergast, M.L., Podus, D., Chang, E., 1998. A meta-analysis of drug treatment effectiveness. Poster presented at the meeting of the College on the Problems of Drug Dependence, Scottsdale, AZ.
56. Public Health Service, 1988. Report of the Second Public Health Service AIDS Prevention and Control Conference. Public Health Rep. 193 (Suppl. 1), 66-77.
57. Rhoades, H.M., Creson, D., Elk, R., Schmitz, J., Grabowski, J., 1998. Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am. J. Public Health 88, 34-39.
58. Saxon, A.J., Calsyn, D.A., Jackson, T.R., 1994. Longitudinal changes in injection behaviors in a cohort of injection drug users. Addiction 89, 191-202.
59. Selwyn, P.A., Feingold, A., Iezza, A., Satyadeo, M., Coley, J., Torres, R., Shaw, J.F.M., 1989. Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program. Ann. Intern. Med. 111 (9), 761-763.
60. Serpelloni, G., Carrieri, M.P., Rezza, G., Morganti, S., Gomma, M., Binkin, N., 1994. Methadone treatment as a determinant of HIV risk reduction among injection drug users: a nested case-control study. AIDS Care 6, 215-220.
61. Shore, R.E., Marmor, M., Titus, S., Des Jarlais, D.C., 1996. Methadone maintenance and other factors associated with intraindividual temporal trends in injection-drug use. J. Subst. Abuse Treat. 13, 241-248.
62. Simpson, D.D., 1993. Drug treatment evaluation research in the United States. Psychol. Addict. Behav. 7, 120-128.
63. Simpson, D.D., Savage, L.J., Lloyd, M.R., 1979. Follow-up evaluation of treatment of drug abuse during 1969 to 1972. Arch. Gen. Psychiatry 36, 772-780.
64. Sisk, J.E., Hatziandreu, E.J., Hughes, R., 1990. The Effectiveness of Drug Abuse Treatment: Implications for Controlling AIDS/HIV Infection (OTA background paper no. 6). Office of Technology Assessment, Washington, DC.
65. Stark, K., Müller, R., Bienzle, U., Guggenmoos-Holzmann, I., 1996. Methadone maintenance treatment and HIV risk-taking behavior among injecting drug users in Berlin. J. Epidemiol. Community Health 50, 534-537.
66. Stephens, R.C., Feucht, T.E., Roman, S.W., 1991. Effects of an intervention program on AIDS-related drug and needle behavior among intravenous drug users. Am. J. Public Health 81, 568-571.
67. Turner, C.F., Miller, H.G., Moses, L.E. (Eds.), 1989. AIDS Sexual Behavior and Intravenous Drug Use. National Academy Press, Washington, DC.
68. Umbricht-Schneiter, A., Ginn, D.H., Pabst, K.M., Bigelow, G.E., 1994. Providing medical care to methadone clinic patients: referral vs. on-site care. Am. J. Public Health 84 (2), 207-210.
69. Williams, A.B., McNelly, E.A., Williams, A.E., D'Aquila, R.T., 1992. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users. AIDS Care 4, 35-41.